表紙:核酸増幅検査の世界市場:技術別、アプリケーション別、地域別の予測(2026年まで)- COVID-19の累積的影響
市場調査レポート
商品コード
1034532

核酸増幅検査の世界市場:技術別、アプリケーション別、地域別の予測(2026年まで)- COVID-19の累積的影響

Nucleic Acid Amplification Testing Market Research Report by Technique, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
核酸増幅検査の世界市場:技術別、アプリケーション別、地域別の予測(2026年まで)- COVID-19の累積的影響
出版日: 2021年10月28日
発行: 360iResearch LLP
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の核酸増幅検査の市場規模は、2020年に21億9,867万米ドルとなり、2021年には24億6,977万米ドルに達し、その後はCAGR 12.66%で推移し、2026年には44億9,754万米ドルに達すると予想されています。

当レポートは、世界の核酸増幅検査市場について調査しており、市場の機会や課題、成長および抑制要因、COVID-19の累積的影響、技術・アプリケーション・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションと範囲
  • 調査対象期間
  • 通貨と価格
  • 言語
  • 制限事項
  • 前提条件
  • 利害関係者

第2章 調査手法

  • 定義:調査目的
  • 決定:調査計画
  • 準備:調査機器
  • 収集:データソース
  • 分析:データの解釈
  • 策定:データ検証
  • 公開:調査レポート
  • 繰り返し:レポートの更新

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場の洞察

  • 市場力学
    • 成長要因
    • 抑制要因
    • 市場機会
    • 課題
  • COVID-19の累積的影響

第6章 技術別の核酸増幅検査市場

  • プローブ増幅システム
  • 信号増幅システム
  • ターゲット増幅システム

第7章 アプリケーション別の核酸増幅検査市場

  • 遺伝性疾患およびミトコンドリア異常
  • 感染症
    • バクテリア
    • ウイルス
  • オーダーメイド医療

第8章 南北アメリカの核酸増幅検査市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の核酸増幅検査市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ

第10章 欧州、中東・アフリカの核酸増幅検査市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 主要企業別市場シェア分析
  • 競合シナリオ
    • 合併・買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 評価、認知、拡大

第12章 企業プロファイル

  • Abbott Laboratories Inc
  • Beckman Coulter, Inc.
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Eiken Chemical Co., Ltd.
  • GE Healthcare
  • Genomtec SA
  • Grifols SA
  • Grifols, S.A.
  • Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Jena Bioscience GmbH
  • Lucigen Corporation
  • Mast Group Ltd.
  • Novartis International AG
  • OptiGene Limited
  • PREMIER Biosoft
  • QIAGEN GmbH
  • Quidel Corporation
  • Siemens Healthcare GmbH
  • Sysmex Corporation
  • TwistDx Limited

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET: MARKET DYNAMICS
  • FIGURE 3. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2020 VS 2026 (%)
  • FIGURE 4. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2020 VS 2026 (USD MILLION)
  • FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2026
  • FIGURE 6. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PROBE AMPLIFICATION SYSTEMS, 2018-2026 (USD MILLION)
  • FIGURE 7. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PROBE AMPLIFICATION SYSTEMS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 8. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SIGNAL AMPLIFICATION SYSTEMS, 2018-2026 (USD MILLION)
  • FIGURE 9. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SIGNAL AMPLIFICATION SYSTEMS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TARGET AMPLIFICATION SYSTEMS, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TARGET AMPLIFICATION SYSTEMS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 13. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 15. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY CANCER, 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY CANCER, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC AND MITOCHONDRIAL DISORDERS, 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC AND MITOCHONDRIAL DISORDERS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BACTERIA, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BACTERIA, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY VIRUS, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY VIRUS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 28. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 29. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 30. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 31. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 32. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 33. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 34. AUSTRALIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 35. CHINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 36. INDIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 37. INDONESIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 38. JAPAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 39. MALAYSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 40. PHILIPPINES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 41. SINGAPORE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 42. SOUTH KOREA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 43. TAIWAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 44. THAILAND NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 45. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 46. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 47. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 48. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 49. NETHERLANDS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 50. QATAR NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 51. RUSSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 52. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 53. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 54. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 55. UNITED ARAB EMIRATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 56. UNITED KINGDOM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 57. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET: FPNV POSITIONING MATRIX
  • FIGURE 58. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 59. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2026 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PROBE AMPLIFICATION SYSTEMS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SIGNAL AMPLIFICATION SYSTEMS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 6. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TARGET AMPLIFICATION SYSTEMS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 7. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC AND MITOCHONDRIAL DISORDERS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BACTERIA, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY VIRUS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 14. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 15. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 16. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 17. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 18. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 19. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 20. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 21. AUSTRALIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 22. CHINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 23. INDIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 24. INDONESIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 25. JAPAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 26. MALAYSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 27. PHILIPPINES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 28. SINGAPORE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 29. SOUTH KOREA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 30. TAIWAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 31. THAILAND NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 32. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 33. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 34. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 35. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 36. NETHERLANDS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 37. QATAR NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 38. RUSSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 39. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 40. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 41. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 42. UNITED ARAB EMIRATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 43. UNITED KINGDOM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 44. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET: SCORES
  • TABLE 45. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET: BUSINESS STRATEGY
  • TABLE 46. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET: PRODUCT SATISFACTION
  • TABLE 47. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET: RANKING
  • TABLE 48. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 49. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET: MERGER & ACQUISITION
  • TABLE 50. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 51. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 52. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET: INVESTMENT & FUNDING
  • TABLE 53. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 54. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET: LICENSE & PRICING
目次
Product Code: MRR-AD36CD897FCC

The Global Nucleic Acid Amplification Testing Market size was estimated at USD 2,198.67 million in 2020 and expected to reach USD 2,469.77 million in 2021, at a CAGR 12.66% to reach USD 4,497.54 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Nucleic Acid Amplification Testing to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Technique, the market was studied across Probe amplification systems, Signal amplification systems, and Target amplification systems.
  • Based on Application, the market was studied across Cancer, Genetic and Mitochondrial Disorders, Infectious Diseases, and Personalized Medicine. The Infectious Diseases is further studied across Bacteria and Virus.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Nucleic Acid Amplification Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Nucleic Acid Amplification Testing Market, including Abbott Laboratories Inc, Beckman Coulter, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Eiken Chemical Co., Ltd., GE Healthcare, Genomtec SA, Grifols SA, Grifols, S.A., Hoffmann-La Roche Ltd, Illumina, Inc., Jena Bioscience GmbH, Lucigen Corporation, Mast Group Ltd., Novartis International AG, OptiGene Limited, PREMIER Biosoft, QIAGEN GmbH, Quidel Corporation, Siemens Healthcare GmbH, Sysmex Corporation, and TwistDx Limited.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Nucleic Acid Amplification Testing Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Nucleic Acid Amplification Testing Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Nucleic Acid Amplification Testing Market?
  • 4. What is the competitive strategic window for opportunities in the Global Nucleic Acid Amplification Testing Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Nucleic Acid Amplification Testing Market?
  • 6. What is the market share of the leading vendors in the Global Nucleic Acid Amplification Testing Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Nucleic Acid Amplification Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Define: Research Objective
  • 2.3. Determine: Research Design
  • 2.4. Prepare: Research Instrument
  • 2.5. Collect: Data Source
  • 2.6. Analyze: Data Interpretation
  • 2.7. Formulate: Data Verification
  • 2.8. Publish: Research Report
  • 2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for advanced diagnostic testing
      • 5.1.1.2. Rising prevalence of diseases associated with vectors like bacteria & viruses
      • 5.1.1.3. Increasing investment for development of new biotechnological diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent government regulation imposed on the nucleic acid amplification testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing acceptance of nucleic acid amplification testing in emerging economies
      • 5.1.3.2. Favorable government initiative to promote testing
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of trained technical expertise and high sensitivity
  • 5.2. Cumulative Impact of COVID-19

6. Nucleic Acid Amplification Testing Market, by Technique

  • 6.1. Introduction
  • 6.2. Probe amplification systems
  • 6.3. Signal amplification systems
  • 6.4. Target amplification systems

7. Nucleic Acid Amplification Testing Market, by Application

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Genetic and Mitochondrial Disorders
  • 7.4. Infectious Diseases
    • 7.4.1. Bacteria
    • 7.4.2. Virus
  • 7.5. Personalized Medicine

8. Americas Nucleic Acid Amplification Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Nucleic Acid Amplification Testing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand

10. Europe, Middle East & Africa Nucleic Acid Amplification Testing Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Key Player
  • 11.4. Competitive Scenario
    • 11.4.1. Merger & Acquisition
    • 11.4.2. Agreement, Collaboration, & Partnership
    • 11.4.3. New Product Launch & Enhancement
    • 11.4.4. Investment & Funding
    • 11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories Inc
  • 12.2. Beckman Coulter, Inc.
  • 12.3. Becton, Dickinson, and Company
  • 12.4. Bio-Rad Laboratories, Inc.
  • 12.5. bioMerieux SA
  • 12.6. Eiken Chemical Co., Ltd.
  • 12.7. GE Healthcare
  • 12.8. Genomtec SA
  • 12.9. Grifols SA
  • 12.10. Grifols, S.A.
  • 12.11. Hoffmann-La Roche Ltd
  • 12.12. Illumina, Inc.
  • 12.13. Jena Bioscience GmbH
  • 12.14. Lucigen Corporation
  • 12.15. Mast Group Ltd.
  • 12.16. Novartis International AG
  • 12.17. OptiGene Limited
  • 12.18. PREMIER Biosoft
  • 12.19. QIAGEN GmbH
  • 12.20. Quidel Corporation
  • 12.21. Siemens Healthcare GmbH
  • 12.22. Sysmex Corporation
  • 12.23. TwistDx Limited

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing